Relation between serum lipoprotein (a) and residual lesion stenosis of coronary artery after myocardial infarction without reperfusion therapy

Japanese Heart Journal

Volumn 45, Issue 3, 2004, Pages 397-407

  Matsuda, Shigeru ^a   Arima, Mizuhiro ^a   Ohigawa, Tetsuya ^a   Tanimoto, Kohsei ^a   Takagi, Atsutoshi ^a   Kanoh, Tatsuji ^a   Yamagami, Shinichiro ^b   Daida, Hiroyuki ^c  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Lipoprotein (a)

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HEPARIN; LIPOPROTEIN A; NITRIC ACID DERIVATIVE; TRIACYLGLYCEROL; LIPID;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIET RESTRICTION; DISEASE CLASSIFICATION; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HEART MUSCLE REPERFUSION; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CORONARY BLOOD VESSEL; HEART INFARCTION; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RISK FACTOR; SEX DIFFERENCE;

AGED; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 3442875296     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.45.397     Document Type: Article

References (25)

1. Berg K. A NEW SERUM TYPE SYSTEM IN MAN - THE Lp SYSTEM. Acta Pathol Microbiol Scand 1963; 59: 369-82.
2. Koltringer P, Jurgens G. A dominant role of lipoprotein (a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis 1985; 58: 187-98.
3. Armstrong VW, Cremer P, Eberle E, et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986; 62: 249-57.
4. Dahlen GH, Srinivasan SR, Stenlund H, Wattigney WA, Wall S, Berenson GS. The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States. J Intern Med 1998; 244: 417-24.
5. Stubbs P, Seed M, Lane D, Collinson P, Kendall F, Noble M. Lipoprotein (a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. Eur Heart J 1998; 19: 1355-64.
6. McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 330: 132-7.
7. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein (a). Nature 1989; 339: 301-3.
8. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-5.
9. von Hodenberg E, Pestel E, Kreuzer J, Freitag M, Bode C. Effects of lipoprotein(a) on thrombolysis. Chem Phys Lipids 1994; 67-68: 381-5.
10. MBewu AD, Durrington PN, Mackness MI, Hunt L, Turkie WH, Creamer JE. Serum Lp (a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction. Br Heart J 1994; 71: 316-21.
11. Brugemann J, van der Meer J, Hillege HL, et al. Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in nonpatency. Int J Cardiol 1994; 45: 109-13.
12. Honda Y, Oshima S, Ogawa H, et al. Plasma lipoprotein (a) levels and fibrinolytic activity in acute myocardial infarction. Jpn Circ J 1994; 58: 869-76.
13. Tokgozoglu SL, Ozmen F, Kabuku M, et al. Does increased lipoprotein (a) impair the effectiveness of thrombolysis with streptokinase? Angiology 1995; 46: 727-31.
14. Haider AW, Andreotti F, Thompson GR, Kluft C, Maseri A, Davies GJ. Serum lipoprotein (a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction. Circulation 1996; 94: 2072-6.
15. Moliterno DJ, Lange RA, Meidell RS, et al. Relation of plasma lipoprotein (a) to infarct artery patency in survivors of myocardial infarction. Circulation 1993; 88: 935-40.
16. Austen WG, Edwards JE, Frye RL, et al. "A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association." Circulation 1975; 51 (Suppl 4): 5-40.
17. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
18. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992; 326: 242-50.
19. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992; 326: 310-8.
20. Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337: 8745, 809-12.
21. Ioka T, Tasaki H, Yashiro A, et al. Association between plasma lipoprotein(a) and endothelial dysfunction in normocholesterolemic and non-diabetic patients with angiographically normal coronary arteries. Circ J 2002; 66: 267-71.
22. Sunayama S, Daida H, Mokuno H, et al. Lack of increased coronary atherosclerotic risk due to elevated lipoprotein (a) in women ≥ 55 years of age. Circulation 1996; 94: 1263-8.
23. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91: 298-303.
24. Hasdai D, Lerman A, Rihal CS, et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J 1999; 137 (4 Pt 1): 612-20.
25. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 32: 641-7.